NGVT:NYE-Ingevity Corporation

EQUITY | Chemicals | New York Stock Exchange

Last Closing

USD 103.71

Change

0.00 (0.00)%

Market Cap

USD 2.15B

Volume

0.32M

Analyst Target

USD 117.50
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Ingevity Corp provides specialty chemicals & carbon materials and technologies. The Company's products are used in asphalt paving, oil exploration & production, agrochemicals, adhesives, lubricants, publication inks and automotive components.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2019-03-24 )

Largest Industry Peers for Chemicals

Symbol Name Price(Change) Market Cap
DOW Dow Inc

+0.33 (+0.58%)

USD 42.26B
CE Celanese Corporation

+0.49 (+0.32%)

USD 18.14B
HUN Huntsman Corporation

+0.42 (+1.77%)

USD 4.46B
BAK Braskem SA Class A

+0.11 (+1.27%)

USD 3.45B
TROX Tronox Holdings PLC

+0.95 (+5.87%)

USD 2.56B
REX REX American Resources Corpora..

+0.03 (+0.05%)

USD 1.03B
WLKP Westlake Chemical Partners LP

+0.12 (+0.55%)

USD 0.77B
ASIX AdvanSix Inc

-0.57 (-2.10%)

USD 0.72B
LXU Lsb Industries Inc

N/A

USD 0.62B
VHI Valhi Inc

-0.51 (-3.29%)

USD 0.46B

ETFs Containing NGVT

SPUN 0.00 % 0.55 %

N/A

N/A
YXM.B:CA 0.00 % 0.69 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Chemicals) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 23.92% 87% B+ 89% A-
Dividend Return N/A N/A N/A N/A F
Total Return 23.92% 87% B+ 88% B+
Trailing 12 Months  
Capital Gain 41.06% 100% F 97% N/A
Dividend Return N/A N/A N/A N/A F
Total Return 41.06% 100% F 96% N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A F
Dividend Return N/A N/A N/A N/A F
Total Return N/A N/A N/A N/A F
Average Annual (5 Year Horizon)  
Capital Gain 29.70% 96% N/A 96% N/A
Dividend Return 29.70% 92% A 96% N/A
Total Return N/A N/A N/A N/A F
Risk Return Profile  
Volatility (Standard Deviation) 29.01% 42% F 19% F
Risk Adjusted Return 102.36% 92% A 87% B+
Market Capitalization 2.15B 60% D- 78% C+

Key Financial Ratios

  Ratio vs. Industry/Classification (Chemicals) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 18.80 31% 23%
Price/Book Ratio 13.40 7% 5%
Price / Cash Flow Ratio 4.58 27% 25%
Price/Free Cash Flow Ratio 27.51 27% 17%
Management Effectiveness  
Return on Equity 52.08% 91% 95%
Return on Invested Capital 24.76% 89% 89%
Return on Assets 13.07% 93% 93%
Debt to Equity Ratio 231.25% 25% 14%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.